Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Pamela Rheinfrank v. Abbott Laboratories, Inc., et al
Case Number:
16-3347
Court:
Nature of Suit:
Companies
Sectors & Industries:
-
February 21, 2017
6th Circ. Upholds Abbott Labs' Depakote Birth Defect Win
The Sixth Circuit on Tuesday turned down a request for a new trial by a mother alleging that her child's birth defects were caused by Abbott Laboratories Inc.'s anti-seizure drug Depakote, saying that her arguments about what the U.S. Food and Drug Administration should have done were too speculative.
-
December 01, 2016
Experts Hampered In Depakote Birth Defect Trial, Mom Says
A mother alleging her child's birth defects were caused by Abbott Laboratories Inc.'s anti-seizure drug Depakote pressed the Sixth Circuit for a new trial, saying Thursday the lower court wrongly limited crucial testimony from three doctors who have called the medication's warning labels inadequate.
-
November 14, 2016
Mom Says Mo. Appeals Ruling Backs Her Depakote Claims
A woman asking for a new trial over claims that Abbott Laboratories Inc. and AbbVie Inc.'s drug Depakote caused her child's birth defects told the Sixth Circuit on Monday that a state appeals court's ruling shows that Abbott can't argue it was impossible to warn of the drug's full risks.
-
July 21, 2016
Abbott Can't Put Depakote Blame On FDA, Mom Tells 6th Circ.
A mother who lost a trial over her claims that Abbott and AbbVie Inc.'s epilepsy drug Depakote caused her child's birth defects urged the Sixth Circuit on Wednesday to grant her a new trial, saying the court wrongfully let the drugmaker "hide behind the FDA" and excluded crucial trial testimony.
-
July 05, 2016
Abbott Tells 6th Circ. Depakote Testimony Correctly Limited
Abbott Labs urged the Sixth Circuit on Tuesday to affirm its November trial win over birth defects allegedly caused by Depakote, saying the trial court was right to prohibit four experts from testifying about what should have appeared on the drug's labels.
-
June 02, 2016
Mom Tells 6th Circ. Depakote Birth Defect Trial Court Erred
The mother who lost at trial in November on her claims that her child's birth defects were caused by Abbott Laboratories' and AbbVie's epilepsy drug Depakote told the Sixth Circuit on Wednesday the lower court erred by excluding expert testimony and important jury instructions regarding drug labels.